Form 4: Roivant Sciences Director Ilan Oren Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Director Ilan Oren disposed of 3,487 common shares of Roivant Sciences Ltd. to cover tax withholding obligations related to vested RSUs.
Summary
- On September 12, 2024, Ilan Oren, a director of Roivant Sciences Ltd., disposed of 3,487 common shares.
- The shares were sold at a price of $12.12 per share.
- This transaction was a 'net settlement' by Roivant Sciences to satisfy tax withholding obligations related to the vesting and settlement of previously granted Restricted Stock Units (RSUs).
- Following the transaction, Ilan Oren directly owns 95,553 common shares of Roivant Sciences Ltd.
Sentiment
Score: 5
Explanation: The document describes a routine transaction related to tax obligations, which is neither particularly positive nor negative. It's a neutral event in terms of investment sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, such as directors and officers. This allows investors to monitor their trading activity and assess their confidence in the company's prospects.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations related to vested RSUs.
Key Dates
| Date | Description |
|---|---|
| 09/12/2024 | Date of transaction: Ilan Oren disposed of 3,487 common shares. |
| 09/16/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.